Literature DB >> 1608890

Initial studies on the N-glucosylation of phenobarbital by mouse liver microsomes using a radiochemical high-performance liquid chromatographic (HPLC) method.

W H Soine1, H Safi, R B Westkaemper.   

Abstract

A method is described for the assay of phenobarbital N-glucosylation using UDP-D-[6-3H]glucose. The radioactive phenobarbital N-glucoside conjugates [(5R)-PBG, (5S)-PBG] formed during the incubations were resolved from each other and from uncharacterized radioactive products by semipreparative HPLC. The product ratio of the N-glucosides of (5R)-PBG/(5S)-PBG was 2.9 for the crude liver homogenate and 3.0 +/- 0.5 for the microsomes. Magnesium was necessary for optimal activity. The Km values for formation of (5R)-PBG, (5S)-PBG, and (5R + 5S)-PBG were 1.55 +/- 0.35, 1.27 +/- 0.14, and 1.47 +/- 0.21 mM, respectively. The Vmax values for formation of (5R)-PBG, (5S)-PBG, and (5R + 5S)-PBG were 1.34 +/- 0.05 x 10(-6), 0.43 +/- 0.01 x 10(-6), and 1.77 +/- 0.04 x 10(-6) mumol/min/mg microsomal protein, respectively. It was observed that at concentrations greater than 5 mM sodium phenobarbital, inhibition of formation of phenobarbital N-glucosides occurred. The product ratio of (5R)-PBG/(5S)-PBG is comparable to that observed in the urinary excretion studies with the mouse and opposite to that observed in urinary excretion studies in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1608890     DOI: 10.1023/a:1015889707922

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Identification of phenobarbital N-glucosides as urinary metabolites of phenobarbital in mice.

Authors:  W H Soine; P J Soine; T M England; J W Ferkany; B E Agriesti
Journal:  J Pharm Sci       Date:  1991-02       Impact factor: 3.534

2.  Direct detection of 1-(beta-D-glucopyranosyl)phenobarbital in human urine.

Authors:  W H Soine; V O Bhargava; L K Garrettson
Journal:  Drug Metab Dispos       Date:  1984 Nov-Dec       Impact factor: 3.922

3.  A unified method for the assay of uridine diphosphoglucuronyltransferase activities toward various aglycones using uridine diphospho[U-14C]glucuronic acid.

Authors:  S K Bansal; T Gessner
Journal:  Anal Biochem       Date:  1980-12       Impact factor: 3.365

4.  A method for the study of N-glucosidation in vitro--amobarbital-N-glucoside formation in incubations with human liver.

Authors:  B K Tang; G Carro-Ciampi
Journal:  Biochem Pharmacol       Date:  1980-07-15       Impact factor: 5.858

5.  Acyl glucuronidation and glucosidation of pranoprofen, a 2-arylpropionic acid derivative, in mouse liver and kidney homogenates.

Authors:  N Arima
Journal:  J Pharmacobiodyn       Date:  1990-12

6.  Stereoselective acyl glucuronidation and glucosidation of pranoprofen, a 2-arylpropionic acid derivative, in mice in vivo.

Authors:  N Arima
Journal:  J Pharmacobiodyn       Date:  1990-12

7.  Stereochemical characterization of the diastereomers of the phenobarbital N-beta-D-glucose conjugate excreted in human urine.

Authors:  W H Soine; P J Soine; S E Mongrain; T M England
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

8.  Studies of mammalian glucoside conjugation.

Authors:  T Gessner; A Jacknowitz; C A Vollmer
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

9.  The formation of glucosides of isoflavones and of some other phenols by rabbit liver microsomal fractions.

Authors:  R S Labow; D S Layne
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

10.  The fate of phenobarbitone in children in hypothermia and at normal body temperature.

Authors:  D Kadar; B K Tang; A W Conn
Journal:  Can Anaesth Soc J       Date:  1982-01
View more
  2 in total

1.  Inhibition of phenobarbitone N-glucosidation by valproate.

Authors:  I Bernus; R G Dickinson; W D Hooper; M J Eadie
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

2.  Phenobarbital N-glucosylation by human liver microsomes.

Authors:  Sheela G Paibir; William H Soine; Diana F Thomas; Robert A Fisher
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.